ACADIAN ASSET MANAGEMENT LLC - ONCOGENEX PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 57 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$13,000
+44.4%
12,9410.0%0.00%–
Q1 2016$9,000
-25.0%
12,941
+32.9%
0.00%–
Q4 2015$12,000
+20.0%
9,737
+115.9%
0.00%–
Q3 2015$10,000
-23.1%
4,511
-24.8%
0.00%–
Q1 2015$13,000–5,998–0.00%–
 Download
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q1 2015
NameSharesValueWeighting ↓
Virtu KCG Holdings LLC 86,824$31,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$17,0000.00%
DEUTSCHE BANK AG\ 1,405$00.00%
CITIGROUP INC 9,751$4,0000.00%
GOLDMAN SACHS GROUP INC 17,281$6,0000.00%
MORGAN STANLEY 4,250$2,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 48,944$18,0000.00%
BlackRock Inc. 927,688$334,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 6,600$2,0000.00%
Bank of New York Mellon Corp 62,846$22,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders